(Q39298850)

10 September 2017

title

Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice (English)

1 reference

10 September 2017

1 reference

1 reference

hepatocellular carcinoma

1 reference

Wei-Hsiang Lin

1

1 reference

10 September 2017

Shiou-Hwei Yeh

2

1 reference

10 September 2017

Wan-Jen Yang

3

1 reference

10 September 2017

Kun-Huei Yeh

4

1 reference

10 September 2017

Toshiyoshi Fujiwara

5

1 reference

10 September 2017

Aisuke Nii

6

1 reference

10 September 2017

Stanley Shi-Chung Chang

7

1 reference

10 September 2017

Pei-Jer Chen

8

1 reference

10 September 2017

language of work or name

English

0 references

publication date

23 November 2012

1 reference

International Journal of Cancer

10 September 2017

published in

1 reference

10 September 2017

volume

132

1 reference

10 September 2017

issue

6

1 reference

10 September 2017

page(s)

1451-1462

1 reference

Estimating the world cancer burden: Globocan 2000.

10 September 2017

cites work

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

Viral hepatocarcinogenesis: from infection to cancer

21 January 2018

1 reference

Current management strategy of hepatocellular carcinoma

21 January 2018

1 reference

Treatment options for hepatocellular carcinoma

21 January 2018

1 reference

Molecular targeted therapies in hepatocellular carcinoma

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter

21 January 2018

1 reference

Telomerase-specific replication-selective virotherapy for human cancer

21 January 2018

1 reference

Telomerase-dependent oncolytic adenovirus for cancer treatment

21 January 2018

1 reference

A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors

21 January 2018

1 reference

Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model

21 January 2018

1 reference

Combination of oncolytic adenovirotherapy and Bax gene therapy in human cancer xenografted models. Potential merits and hurdles for combination therapy.

21 January 2018

1 reference

Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus

21 January 2018

1 reference

Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors

21 January 2018

1 reference

The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma

21 January 2018

1 reference

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

21 January 2018

1 reference

Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.

21 January 2018

1 reference

Selectivity of oncolytic viral replication prevents antiviral immune response and toxicity, but does not improve antitumoral immunity

21 January 2018

1 reference

Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses

21 January 2018

1 reference

Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model

21 January 2018

1 reference

Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice

21 January 2018

1 reference

In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus

21 January 2018

1 reference

Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis

21 January 2018

1 reference

Restricted replication of adenovirus type 2 in mouse Balb/3T3 cells

21 January 2018

1 reference

Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection

21 January 2018

1 reference

Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma

21 January 2018

1 reference

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

21 January 2018

1 reference

Adenovirus serotype 5 hexon mediates liver gene transfer

21 January 2018

1 reference

Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo

21 January 2018

1 reference

A cytokine-mediated link between innate immunity, inflammation, and cancer

21 January 2018

1 reference

Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27770

1 reference

10 September 2017

1 reference